Priapism following olanzapine administration in a patient with multiple sclerosis.
Heckers
S
S
Avery D. Weisman Psychiatry Consultation Service, Massachusetts General Hospital, Harvard Medical School, Boston, USA. heckers@psych.mgh.harvard.edu
Anick
D
D
Boverman
J F
JF
Stern
T A
TA
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001569:Benzodiazepines; D001714:Bipolar Disorder / Q000139:chemically induced / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D000077152:Olanzapine; D010410:Penile Erection / Q000187:drug effects; D010890:Pirenzepine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D011317:Priapism / Q000139:chemically induced* / Q000175:diagnosis
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000324:Adrenocorticotropic Hormone; D000077152:Olanzapine